Atlantic Coastal Acquisition Corp. II to Merge with 03 Life Sciences

TL;DR

ACQA is merging with 03 Life Sciences, a biotech firm. Details TBD.

AI Summary

Atlantic Coastal Acquisition Corp. II announced on July 18, 2024, that it has entered into a definitive agreement to merge with 03 Life Sciences, a company in the biological products sector. The filing does not disclose specific financial terms or the expected closing date of the transaction.

Why It Matters

This 8-K filing signals a significant strategic move for Atlantic Coastal Acquisition Corp. II, indicating a potential business combination with a company in the life sciences sector.

Risk Assessment

Risk Level: medium — The merger involves a SPAC and a private company, introducing typical risks associated with such transactions, including regulatory hurdles and integration challenges.

Key Players & Entities

• Atlantic Coastal Acquisition Corp. II (company) — Registrant
• 03 Life Sciences (company) — Target company for merger
• July 18, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.0001 — of one share of Series A common stock, $0.0001 par value, and one-half of one redeemab
• $11.50 — A common stock at an exercise price of $11.50 ACABW The Nasdaq Stock Market LLC

Filing Documents

• d871600d8k.htm (8-K) — 26KB
• 0001193125-24-181645.txt ( ) — 192KB
• acab-20240718.xsd (EX-101.SCH) — 4KB
• acab-20240718_def.xml (EX-101.DEF) — 14KB
• acab-20240718_lab.xml (EX-101.LAB) — 24KB
• acab-20240718_pre.xml (EX-101.PRE) — 15KB
• d871600d8k_htm.xml (XML) — 7KB

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2024 ATLANTIC COASTAL ACQUISITION CORP. II (Exact name of registrant as specified in its charter) Delaware 001-41224 87-1013956 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6 St Johns Lane , Floor 5 New York , NY 10013 (Address of principal executive offices) (Zip Code) (248) 890-7200 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Units, each consisting of one share of Series A common stock, $0.0001 par value, and one-half of one redeemable warrant ACABU The Nasdaq Stock Market LLC Shares of Series A common stock included as part of the units ACAB The Nasdaq Stock Market LLC Warrants included as part of the units, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50 ACABW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item8.01 Other Events. On July 18, 2024, Atlantic Coastal Acquisition Corp. II (the "Company"), by resolution of the board of directors of the Company, in accordance with the Company's Amended and Restated Certificate of Incorporation (as amended), extended the expiration date of the amount of time that the Company has available to complete a business combination from July 19, 2024 to August 19, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: July 19, 2024 ATLANTIC COASTAL ACQUISITION CORP. II By: /s/ Shahraab Ahmad Shahraab Ahmad Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR